Using genome-wide CRISPR library screening with library resistant DCK to find new sources of Ara-C drug resistance in AML

Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification

(2016) Richard M Deans et al.   Nature Chemical Biology

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

(2015) Silvana Konermann et al.   NATURE

RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia

(2015) Ajay Abraham et al.   PHARMACOGENOMICS

Using RNA-seq and targeted nucleases to identify mechanisms of drug resistance in acute myeloid leukemia

(2014) Susan K. Rathe et al.   Scientific Reports

Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells

(2013) Ophir Shalem et al.   SCIENCE

Multiplex Genome Engineering Using CRISPR/Cas Systems

(2013) L. Cong et al.   SCIENCE

Does immune suppression during stress occur to promote physical performance?

(2012) L. B. Martin et al.   JOURNAL OF EXPERIMENTAL BIOLOGY

Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells

(2011) George Schlossmacher et al.   JOURNAL OF ENDOCRINOLOGY

Deoxycytidine kinase is downregulated in Ara-C-resistant acute myeloid leukemia murine cell lines

(2010) S K Rathe et al.   LEUKEMIA

Molecular Classification of Acute Myeloid Leukemia: Are We There Yet?

(2008) Jerald P. Radich   JOURNAL OF CLINICAL ONCOLOGY